Universal Health Services (UHS) FY2016 results: revenue $9.8 billion, up 8.0% on the year
Universal Health Services Inc. (UHS) reported revenue of $9.8 billion for fiscal 2016, the year ended 31 December 2016, up 8.0% on the year before. Net income was $702 million, up 3.2%, and diluted earnings per share $7.14. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2019.
Revenue
$9.8 billion
+8.0% on the year
FY2010FY2016
Operating margin
13.1%
13.9% a year earlier
FY2010FY2016
Net income
$702 million
+3.2% on the year
FY2010FY2016
Diluted EPS
$7.14
+5.6% on the year
FY2010FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
9,766
9,043
8,205
+8.0%
Operating income
1,281
1,259
1,063
+1.7%
Operating margin
13.1%
13.9%
13.0%
Interest expense
125
113
134
+10.2%
Pre-tax income
1,156
1,146
930
+0.9%
Income tax
409
395
325
+3.5%
Effective tax rate
35.4%
34.5%
34.9%
Net income
702
681
545
+3.2%
Net margin
7.2%
7.5%
6.6%
Diluted EPS
$7.14
$6.76
$5.42
+5.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
1,334
1,068
1,036
+24.9%
Capital expenditure
520
379
391
+37.1%
Free cash flow
814
689
645
+18.1%
Free cash flow margin
8.3%
7.6%
7.9%
Cash from investing
-1,155
-913
-833
Cash from financing
-171
-125
-187
Depreciation and amortisation
417
399
376
+4.5%
Share-based compensation
48.1
40.0
31.1
+20.4%
Buybacks
353
210
101
+68.5%
Dividends paid
38.9
39.5
29.7
-1.7%
Dividend per share
n/a
n/a
$0.30
Diluted shares, weighted
98m
101m
101m
-2.3%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
4,533
4,250
3,736
+6.7%
Non-controlling interest
64.4
59.5
55.1
+8.2%
Redeemable equity
9.3
243
240
-96.2%
Debt
4,136
3,431
3,279
+20.5%
Other liabilities
1,575
1,651
1,642
-4.6%
Total liabilities and equity
10,318
9,634
8,951
+7.1%
Fixed assets
4,331
3,836
3,680
+12.9%
Goodwill
3,784
3,596
3,291
+5.2%
Intangible assets
228
219
98.0
+4.1%
Cash and equivalents
33.7
61.2
32.1
-44.9%
Receivables
1,440
1,302
1,283
+10.5%
Other assets
501
619
568
-19.0%
Total assets
10,318
9,634
8,951
+7.1%
10-K for the year ended 31 December 2016, filed 27 February 2019: the filing.